Intellia Therapeutics, Inc.
Overview
Intellia Therapeutics, Inc. is a leading biotechnology company specializing in the development of CRISPR/Cas9 gene-editing technology to create transformative medicines. The company is focused on developing innovative therapies for genetic diseases and cancer, aiming to provide patients with one-time, potentially curative treatments.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Intellia Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Intellia Therapeutics, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.